U.S. Specialty Stores Stock News

If you are wondering whether Jack Henry & Associates is priced fairly or not, this is where we start connecting the share price to what you are actually paying for. The stock last closed at US$189.16, with returns of 6.1% over the past week, 1.1% over the last month, 6.1% year to date, 11.5% over 1 year, 8.3% over 3 years and 30.2% over 5 years. This gives some context for how the market has been reassessing the company. Recent coverage has focused on Jack Henry & Associates as a key player...

XPO recently renewed its long-standing role as the official transportation partner for the Susan G. Komen 3-Day fundraising walks through March 2029, continuing to provide complimentary transport, storage and logistics support for event materials across all route cities. This extended partnership underscores how XPO integrates community engagement into its core logistics capabilities, highlighting the company’s operational reach and brand positioning beyond purely commercial freight...

First American Financial (FAF) has drawn investor attention after its recent share moves, with the stock up 2.4% over the past day but down 3.1% over the past month. See our latest analysis for First American Financial. At a share price of $61.49, First American Financial’s recent 1 day share price return of 2.42% sits against a softer 30 day share price return of 3.10%. Its 1 year total shareholder return of 10.36% and 5 year total shareholder return of 37.93% point to steadier progress over...

Soho House & Co (SHCO) has recently drawn investor attention after a period of mixed share performance, with the stock showing a small positive 1 year total return alongside negative moves over the past week, month and past 3 months. See our latest analysis for Soho House & Co. The recent 1 day share price return of 2.59% decline, alongside weaker 7 day and 30 day share price returns, suggests fading short term momentum, even as the 3 year total shareholder return of 48.78% points to a...

If you are wondering whether BeOne Medicines is priced for opportunity or already reflecting high expectations, you will want to look closely at what its current valuation is really saying. The stock recently closed at US$337.89, with returns of 8.6% over the last 7 days and 91.2% over the past year, which may signal that the market is reassessing its growth potential or risk profile. Recent coverage around BeOne Medicines has focused on its position within the pharmaceuticals and biotech...

If you are wondering whether Procter & Gamble’s current share price offers fair value or not, you are not alone. This article is built to help you size that up clearly. The stock last closed at US$141.87, with returns of 0.1% over 7 days, 1.5% over 30 days, 0.1% year to date, an 8.2% decline over 1 year and 19.3% over 5 years. These figures may have some investors reassessing both its growth potential and risk profile. Recent coverage has focused on Procter & Gamble as a staple name in...

If you are wondering whether Wyndham Hotels & Resorts is attractively priced right now, it helps to first step back and see how the stock has been behaving. The share price closed at US$81.11, with recent returns of 7.8% over 7 days, 7.2% over 30 days, 7.8% year to date and a 17.7% decline over 1 year, alongside gains of 16.7% over 3 years and 45.6% over 5 years. These mixed returns sit against a backdrop of ongoing industry news around travel demand, brand consolidation and competition...

If you are wondering whether Principal Financial Group's share price still offers value at around US$90, you are not alone, as many investors are asking the same question after its recent run. The stock recently closed at US$90.29, with returns of 1.0% over the past week, 0.1% over the last month, 1.0% year to date and 22.9% over the past year, as well as 12.7% over three years and 102.9% over five years. Recent attention on Principal Financial Group has been shaped by ongoing coverage of...

Rolex lease in Williamsburg puts fresh attention on Empire State Realty Trust Empire State Realty Trust (ESRT) recently signed a lease with Tourneau, LLC for a Rolex retail store at its North Sixth Street Collection in Williamsburg, Brooklyn. The agreement is drawing fresh attention to the REIT's retail footprint and leasing activity. See our latest analysis for Empire State Realty Trust. The Rolex lease and upcoming fourth quarter 2025 results arrive after a weak stretch for the shares, with...

If you are wondering whether Versant Media Group at around US$34.41 is a bargain or a value trap, you are not alone. This article will walk through what the current price might be implying. The stock has had a sharp 26.2% decline over the last 7 days and year to date, which can change how investors think about both its growth potential and its risk. Recent coverage of Versant Media Group has focused on how quickly sentiment can shift around media stocks, with some investors reacting to...

AvalonBay Communities recently confirmed it will release its fourth-quarter 2025 earnings on February 4, 2026, followed by a conference call on February 5 where management will review operating trends, development activity, and outlook. This update comes after Q3 2025 core FFO missed expectations and management flagged softer rental demand in some key markets amid elevated supply. We’ll now examine how the upcoming earnings release and softer rental demand backdrop may influence AvalonBay...

Why Celldex Therapeutics Stock Is Back on Watch With no single headline event driving attention today, Celldex Therapeutics (CLDX) is drawing interest as investors reassess a clinical stage pipeline, recent share performance and the company’s current valuation setup. See our latest analysis for Celldex Therapeutics. The share price at US$27.38 comes after a mixed stretch, with a modest 7 day share price return of 1.37%, a slightly negative 30 day share price return, and a 1 year total...

Central Securities Corp reported in late 2025 that CEO and President John C. Hill bought 500 shares on December 29, increasing his direct holdings to 77,373 shares alongside 901 shares held indirectly through his children. This insider purchase came shortly after the company disclosed that net assets had risen 9.3% to US$1.78 billion as of September 30, 2025, underscoring management’s alignment with shareholder interests. We’ll now examine how the CEO’s insider purchase, alongside rising net...

In early January 2026, Barclays began covering Ryman Hospitality Properties with an Overweight rating, while Fitch Ratings upgraded the company’s credit profile and the REIT declared a cash dividend payable in January 2026, reflecting recent past developments in its financing and capital returns. Together, the new analyst coverage and higher credit rating highlight outside confidence in Ryman’s large group-focused hotel portfolio and its ability to support its balance sheet and dividend...

Worthington Steel recently filed its latest Form 10-Q, showing growth supported by stronger automotive demand and the completed acquisition of Sitem Group, which expands its European footprint and production capabilities. An interesting takeaway is how the Sitem acquisition deepens Worthington Steel’s role in supplying automotive customers in Europe, potentially reshaping its geographic and product mix. We’ll now examine how the Sitem-driven European expansion highlighted in the 10-Q could...

Incyte (INCY) is back in focus after reporting positive Phase 3 frontMIND trial results for tafasitamab plus lenalidomide and R-CHOP in first-line diffuse large B-cell lymphoma, with plans for an expanded filing in 2026. See our latest analysis for Incyte. The frontMIND update comes after a strong run in the shares, with a 30 day share price return of 12.29% and a 90 day share price return of 27.53%, while the 1 year total shareholder return of 51.50% points to momentum building around...

In recent days, GXO Logistics has drawn attention as multiple research firms reiterated positive views on the company while it reshaped its leadership team, including appointing Bomber as Chief Commercial Officer amid reports of increased insider share purchases. Together, upbeat analyst sentiment and insider buying hint that those closest to the business see management changes as important for GXO’s long-term direction. Next, we’ll explore how growing analyst enthusiasm toward GXO’s...

Crocodile Capital Partners’ new US$41 million position in Alpha Metallurgical Resources (AMR), now the fund’s second largest holding, has drawn fresh attention to the stock alongside recent insider purchases and coal demand projections. See our latest analysis for Alpha Metallurgical Resources. Those fund inflows and insider purchases arrive as momentum in Alpha Metallurgical Resources has picked up sharply, with a 35.41% 1 month share price return feeding into a 51.43% 3 month share price...

Simpson Manufacturing recently announced that CEO Mike Olosky and CFO Matt Dunn participated virtually in the CJS Securities 26th Annual New Ideas for the New Year Conference on January 14, 2026, with their presentation webcast on the company’s Investor Relations site and available for replay. At the same time, fresh analysis pointing to slower revenue growth, declining EPS, and weaker returns on invested capital has raised questions about the strength of Simpson’s underlying business...

In recent days, Sphere Entertainment received an upgrade from Seaport Global from Neutral to Buy, following a series of earlier positive analyst views tied to venue performance, sponsorship activity, and attendance trends. At the same time, Sphere’s fundamentals remain mixed, with weak long-term sales growth and constrained free cash flow raising questions about how effectively it can reinvest behind its high-profile partnerships and expanding venue platform. We’ll now explore how Seaport...

Paymentus Holdings (PAY) is back on traders’ screens after a sharp move in its share price, as the company reaffirmed its full year outlook and highlighted fresh integrations across utilities, municipalities, healthcare, and government clients. See our latest analysis for Paymentus Holdings. The latest reaffirmed outlook and new client integrations come after a mixed stretch for the stock, with a 7 day share price return of 6.5%, a 30 day share price return of 12.92%, and a flat 90 day move...

Collegium Pharmaceutical (COLL) shares are reacting to fresh 2026 guidance, with management projecting US$805 million to US$825 million in net product revenue and outlining plans tied to Jornay PM and growth in its pain portfolio. See our latest analysis for Collegium Pharmaceutical. The fresh 2026 guidance and new Nucynta authorized generic agreements arrive after a sharp 42.13% 90 day share price return and a 38.38% one year total shareholder return, even with the recent 6.79% one month...

Rhythm Pharmaceuticals (RYTM) is back in focus after issuing preliminary 2025 guidance, highlighting IMCIVREE revenue estimates and upcoming trial milestones that could influence how investors think about the company’s rare disease franchise. See our latest analysis for Rhythm Pharmaceuticals. Rhythm’s share price has been volatile around the guidance, with a 3.65% 1 day share price return contrasting with a 7 day share price return of negative 3.80%, while the 1 year total shareholder return...

In early January 2026, Valens Semiconductor announced its fourth global MIPI A-PHY design win, with VA7000 chipsets set to power ADAS connectivity for a premium global automotive OEM serving the Chinese market, alongside unveiling the automotive industry's first production-ready MIPI A-PHY-enabled e-mirror developed with Sakae Riken Kogyo in Japan. These developments highlight growing ecosystem adoption of the MIPI A-PHY standard and underline Valens' role in enabling high-bandwidth sensor...